ŞEN, A. Et Al. 2019. Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis. FEBS OPEN BIO , vol.9 , 74.

ŞEN, A., ŞENOL, H., Acar, O. O., Kale, E., DAĞ, A., & TOPÇU, G., (2019). Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis. FEBS OPEN BIO , vol.9, 74.

ŞEN, ALAATTİN Et Al. "Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis," FEBS OPEN BIO , vol.9, 74, 2019

ŞEN, ALAATTİN Et Al. "Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis." FEBS OPEN BIO , vol.9, pp.74, 2019

ŞEN, A. Et Al. (2019) . "Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis." FEBS OPEN BIO , vol.9, p.74.

@article{article, author={ALAATTİN ŞEN Et Al. }, title={Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis}, journal={FEBS OPEN BIO}, year=2019, pages={74} }